Mutagenicity and tumorigenicity of dihydrodiols, diol epoxides, and other derivatives of benzo (f) quinoline and benzo (h) quinoline
Kumar, S.; Sikka, H.C.; Dubey, S.K.; Czech, A.; Geddie, N.; Wang, C.X.; LaVoie, E.J.
Cancer Research 49(1): 20-24
1989
ISSN/ISBN: 0008-5472 PMID: 2908847 Document Number: 330330
The mutagenic activities of benzoquinoline, and their dihydrodiol derivatives were not tumorigenic in newborn mice.
Document emailed within 1 workday
Related Documents
Wood, A.W.; Chang, R.L.; Huang, M.T.; Levin, W.; Lehr, R.E.; Kumar, S.; Thakker, D.R.; Yagi, H.; Jerina, D.M.; Conney, A.H. 1980: Mutagenicity of benzo(e)pyrene and triphenylene tetrahydroepoxides and diol-epoxides in bacterial and mammalian cells Cancer Research 40(6): 1985-1989Hu, X.; Xia, H.; Srivastava, S.K.; Pal, A.; Awasthi, Y.C.; Zimniak, P.; Singh, S.V. 1998: Catalytic efficiencies of allelic variants of human glutathione S-transferase P1-1 toward carcinogenic anti-diol epoxides of benzo[c]phenanthrene and benzo[g]chrysene Cancer Research 58(23): 5340-5343
Wood, A.W.; Wislocki, P.G.; Chang, R.L.; Levin, W.; Lu, A.Y.; Yagi, J.; Hernandez, O.; Herina, D.M.; Conney, A.H. 1976: Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides Cancer Research 36(9 Pt.1): 3358-3366
Cerutti, P.A.; Sessions, F.; Hariharan, P.V.; Lusby, A. 1978: Repair of DNA damage induced by benzo(a)pyrene diol-epoxides i and Ii in human alveolar tumor cells Cancer Research 38(7): 2118-2124
Wislocki, P.G.; Wood, A.W.; Chang, R.L.; Levin, W.; Yagi, H.; Hernandez, O.; Dansette, P.M.; Herina, D.M.; Conney, A.H. 1976: Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells Cancer Research 36(9 Pt.1): 3350-3357
Ginsberg, G.L.; Atherholt, T.B. 1990: DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide Cancer Research 50(4): 1189-1194
Thakker, D.R.; Levin, W.; Buening, M.; Yagi, H.; Lehr, R.E.; Wood, A.W.; Conney, A.H.; Jerina, D.M. 1981: Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides Cancer Research 41(4): 1389-1396
Slaga, T.J.; Bracken, W.J.; Gleason, G.; Levin, W.; Yagi, H.; Jerina, D.M.; Conney, A.H. 1979: Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diastereomeric benzo(a)pyrene 7,8-diol-9,10-epoxides Cancer Research 39(1): 67-71
Newbold, R.F.; Brookes, P. 1976: Exceptional mutagenicity of a benzo(a)pyrene diol epoxide in cultured mammalian cells Nature 261(5555): 52-54
Burgess, J.A.; Stevens, C.W.; Fahl, W.E. 1985: Mutation at separate gene loci in Salmonella typhimurium TA100 related to DNA nucleotide modification by stereoisomeric benzo(a)pyrene 7,8-diol-9,10-epoxides Cancer Research 45(9): 4257-4262
Anzini, M.; Cappelli, A.; Vomero, S.; Botta, M.; Cagnotto, A. 1990: 5-HT and benzodiazepine receptor ligands. III. Synthesis and receptor affinities of 1,2,4-triazolo[4',3':1,6]pyridazino[4,5-b]quinoline and 2,3-dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinoline-1-one derivatives Farmaco 45(11): 1169-1179
Ampy, F.R.; Saxena, S.; Verma, K. 1988: Mutagenicity of benzo(a)pyrene in uninduced tissues from BALB/c mice and Sprague-Dawley rats as an index of possible health risks using the Salmonella mutagenicity assay Cytobios 56(225): 81-87
Mazzei, M.; Roma, G.; Ermili, A.; Cacciatore, C. 1979: Chemical and pharmacological research on pyran derivatives. XIII. Derivatives of 2H-pyrano/3,2-c/quinoline Il Farmaco; Edizione Scientifica 34(6): 469-477
Glatt, H.; Piée, A.; Pauly, K.; Steinbrecher, T.; Schrode, R.; Oesch, F.; Seidel, A. 1991: Fjord- and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells Cancer Research 51(6): 1659-1667
Shen, A.L.; Fahl, W.E.; Wrighton, S.A.; Jefcoate, C.R. 1979: Inhibition of benzo(a)pyrene and benzo(a)pyrene 7,8-dihydrodiol metabolism by benzo(a)pyrene quinones Cancer Research 39(10): 4123-4129
Wislocki, P.G.; Gadek, K.M.; Chou, M.W.; Yang, S.K.; Lu, A.Y. 1980: Carcinogenicity and mutagenicity of the 3,4-dihydrodiols and other metabolites of 7,12-dimethylbenz(a)anthracene and its hydroxymethyl derivatives Cancer Research 40(10): 3661-3664
Wei, Q.; Gu, J.; Cheng, L.; Bondy, M.L.; Jiang, H.; Hong, W.K.; Spitz, M.R. 1996: Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer Cancer Research 56(17): 3975-3979
Ferlin, M.G.; Chiarelotto, G.; Basadonna, O.; Gia, O.; Mobilio, S.; Baccichetti, F.; Carlassare, F. 1989: 1H-pyrrolo[2,3-f]quinoline and isoquinoline derivatives: synthesis and antiproliferative activity Farmaco 44(12): 1141-1155
Savini, L.; Massarelli, P.; Pellerano, C.; Bruni, G. 1993: New quinoline derivatives: synthesis and evaluation for antiinflammatory and analgesic properties--Note II Farmaco 48(6): 805-825
Rádl, S.; Zikán, V.; Smejkal, F. 1985: Preparation of 4-phenoxy and 4-phenylthio derivatives of 1H-pyrazolo[3,4-b]-quinoline with an antiviral effect Ceskoslovenska Farmacie 34(3-4): 119-122